| Product Code: ETC7766605 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Paraneoplastic Neurologic Syndrome Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Paraneoplastic Neurologic Syndrome Market - Industry Life Cycle |
3.4 Jordan Paraneoplastic Neurologic Syndrome Market - Porter's Five Forces |
3.5 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.9 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.10 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Jordan Paraneoplastic Neurologic Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of paraneoplastic neurologic syndrome in Jordan |
4.2.2 Growing awareness among healthcare professionals about the diagnosis and treatment of the syndrome |
4.2.3 Advancements in medical technology and diagnostic techniques for early detection |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities for the diagnosis and treatment of paraneoplastic neurologic syndrome in Jordan |
4.3.2 High cost associated with the treatment and management of the syndrome |
4.3.3 Lack of standardized treatment protocols for the syndrome in Jordan |
5 Jordan Paraneoplastic Neurologic Syndrome Market Trends |
6 Jordan Paraneoplastic Neurologic Syndrome Market, By Types |
6.1 Jordan Paraneoplastic Neurologic Syndrome Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Limbic Encephalitis, 2021- 2031F |
6.1.4 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Subacute Sensory Neuropathy, 2021- 2031F |
6.1.5 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Cerebellar Degeneration, 2021- 2031F |
6.1.6 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Lambert-Eaton Myasthenic Syndrome, 2021- 2031F |
6.1.7 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Peripheral Nerve Hyperexcitability Syndrome, 2021- 2031F |
6.2 Jordan Paraneoplastic Neurologic Syndrome Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Intravenous Immunoglobulin (IVIg), 2021- 2031F |
6.2.4 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Plasmapheresis, 2021- 2031F |
6.2.5 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Physical Therapy, 2021- 2031F |
6.2.6 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Speech Therapy, 2021- 2031F |
6.3 Jordan Paraneoplastic Neurologic Syndrome Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Blood tests, 2021- 2031F |
6.3.3 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Lumbar Puncture, 2021- 2031F |
6.3.4 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.3.5 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Jordan Paraneoplastic Neurologic Syndrome Market, By Symptoms |
6.4.1 Overview and Analysis |
6.4.2 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Gait Disturbance, 2021- 2031F |
6.4.3 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Decreased Muscle Tone, 2021- 2031F |
6.4.4 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Decreased Speech Intelligibility, 2021- 2031F |
6.4.5 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Dysphagia, 2021- 2031F |
6.4.6 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Fine Motor Coordination, 2021- 2031F |
6.4.7 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Visual Problems, 2021- 2031F |
6.4.8 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Dizziness, 2021- 2031F |
6.4.9 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Dizziness, 2021- 2031F |
6.5 Jordan Paraneoplastic Neurologic Syndrome Market, By Dosage |
6.5.1 Overview and Analysis |
6.5.2 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Injection, 2021- 2031F |
6.5.3 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Tablets, 2021- 2031F |
6.5.4 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Jordan Paraneoplastic Neurologic Syndrome Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.6.4 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Jordan Paraneoplastic Neurologic Syndrome Market, By End-Users |
6.7.1 Overview and Analysis |
6.7.2 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Clinic, 2021- 2031F |
6.7.3 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Hospital, 2021- 2031F |
6.7.4 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By , 2021- 2031F |
6.8 Jordan Paraneoplastic Neurologic Syndrome Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.8.3 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.8.4 Jordan Paraneoplastic Neurologic Syndrome Market Revenues & Volume, By , 2021- 2031F |
7 Jordan Paraneoplastic Neurologic Syndrome Market Import-Export Trade Statistics |
7.1 Jordan Paraneoplastic Neurologic Syndrome Market Export to Major Countries |
7.2 Jordan Paraneoplastic Neurologic Syndrome Market Imports from Major Countries |
8 Jordan Paraneoplastic Neurologic Syndrome Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for patients with paraneoplastic neurologic syndrome |
8.2 Percentage increase in healthcare professionals trained in diagnosing and managing the syndrome |
8.3 Number of research studies and clinical trials focused on improving treatment outcomes for the syndrome |
9 Jordan Paraneoplastic Neurologic Syndrome Market - Opportunity Assessment |
9.1 Jordan Paraneoplastic Neurologic Syndrome Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Jordan Paraneoplastic Neurologic Syndrome Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Jordan Paraneoplastic Neurologic Syndrome Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Jordan Paraneoplastic Neurologic Syndrome Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.5 Jordan Paraneoplastic Neurologic Syndrome Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.6 Jordan Paraneoplastic Neurologic Syndrome Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Jordan Paraneoplastic Neurologic Syndrome Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Jordan Paraneoplastic Neurologic Syndrome Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Jordan Paraneoplastic Neurologic Syndrome Market - Competitive Landscape |
10.1 Jordan Paraneoplastic Neurologic Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Jordan Paraneoplastic Neurologic Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here